GlobeNewswire Inc | Mar 2, 2021 04:05PM EST

March 02, 2021

NEWPORT BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in two upcoming virtual investor conferences.

Event: H.C. Wainwright Global Life Sciences ConferenceFormat: Fireside Chat & 1x1 MeetingsDate: Tuesday, March 9, 2021Time: 7:00am ETLocation: Webcast Link Event: Barclays Global Healthcare ConferenceFormat: Fireside Chat & 1x1 MeetingsDate: Wednesday, March 10, 2021Time: 1:15pm ? 1:40pm ETLocation: Webcast Link

Audio webcasts of Evolus fireside chats at the H.C. Wainwright Global Life Sciences Conference and Barclays Global Healthcare Conference will be available on the investor relations section of Evolus website at investors.evolus.com. Replays of the webcasts will be available for 90 days after the date of the presentation.

About Evolus, Inc.

Evolusis a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, theU.S. Food and Drug Administrationapproved Jeuveau (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure technology. Jeuveau is powered byEvolus'unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at:www.evolus.com.

Jeuveau is a registered trademark of Evolus, Inc.

Hi-Pure is a trademark of Daewoong Pharmaceutical Co, Ltd.

Evolus, Inc. Contacts:

Investor Contact:Ashwin Agarwal, Evolus, Inc.Vice President, Finance, Investor Relations & TreasuryTel: +1-949-284-4559Email: IR@Evolus.com

Media Contact:Crystal Muilenburg, Evolus, Inc.Chief Marketing OfficerTel: +1-949-284-4506Email: media@evolus.com